Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
COCP	COCRYSTAL PHARMA INC	$17.09M	-135.10%	-102.40%	-185.41%	-551.50%	0.46	4.57	N/A	N/A	N/A
CODX	CO-DIAGNOSTICS INC	$10.21M	-69.50%	-60.50%	-84.09%	-155.10%	0.13	4.13	39.60%	-3,586.00%	-3,582.18%
THAR	THARIMMUNE INC	$3.51M	-489.30%	-264.30%	1,530.15%	791.50%	-3.04	0.67	N/A	N/A	N/A
ESLA	ESTRELLA IMMUNOPHARMA INC	$31.88M	N/A	-392.70%	198.13%	420.40%	-1.49	0.16	N/A	N/A	N/A
CYCN	CYCLERION THERAPEUTICS INC	$7.78M	-22.60%	-20.70%	-22.71%	-36.00%	0.09	5.03	100.00%	-89.50%	-89.51%
XRTX	XORTX THERAPEUTICS INC	$3.37M	-36.40%	-24.50%	-36.23%	-611.10%	0.28	2.78	N/A	N/A	N/A
CUE	CUE BIOPHARMA INC	$60.71M	-230.10%	-111.20%	-178.91%	-2,975.80%	1.24	1.60	100.00%	-469.30%	-463.15%
DRRX	DURECT CORP	$59.00M	-72.50%	-20.10%	-97.01%	515.70%	2.58	0.99	53.30%	290.10%	371.31%
HLVX	HILLEVAX INC	$104.29M	-44.60%	-37.10%	-41.03%	-61.50%	0.18	26.39	N/A	N/A	N/A
ELUT	ELUTIA INC	$91.15M	N/A	-54.60%	426.69%	-139.50%	-1.81	0.59	44.70%	-90.90%	-73.85%
ENLV	ENLIVEX THERAPEUTICS LTD	$42.45M	-57.70%	-50.50%	-72.71%	-956.50%	0.17	7.20	N/A	N/A	N/A
EQ	EQUILLIUM INC	$35.00M	-74.40%	-46.80%	-127.03%	-290.50%	0.58	2.70	100.00%	-46.00%	-44.81%
INCR	INTERCURE LTD	$78.29M	-15.90%	-8.80%	-6.19%	-7.70%	0.92	1.73	12.70%	-28.40%	-13.88%
EVGN	EVOGENE LTD	$9.07M	N/A	-39.20%	-61.80%	-98.50%	-6.01	1.06	41.10%	-224.80%	-170.88%
GLTO	GALECTO INC	$4.55M	-108.10%	-95.40%	-149.96%	-1,120.10%	0.25	4.96	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$272.14M	-51.20%	-38.20%	-31.98%	-37.50%	0.28	10.52	N/A	N/A	N/A
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$8.39M	-164.80%	-115.40%	-206.17%	-198.10%	0.92	3.35	N/A	N/A	N/A
IVA	INVENTIVA SA	$403.70M	N/A	-195.40%	5,384.47%	-342.30%	-2.12	0.92	100.00%	-1,251.00%	-645.04%
ELAB	PMGC HOLDINGS INC	$2.76M	-69.20%	-58.30%	-54.32%	-846.80%	0.04	22.38	72.50%	459.50%	402.88%
INNV	INNOVAGE HOLDING CORP	$476.60M	-12.30%	-5.80%	-7.98%	-8.60%	1.13	0.78	17.90%	-3.80%	-2.99%
IRIX	IRIDEX CORP	$19.03M	-187.30%	-17.40%	-30.22%	-39.50%	4.21	1.96	39.50%	-11.00%	-10.86%
VTAK	CATHETER PRECISION INC	$68.21M	-245.00%	-91.80%	-82.39%	4,791.10%	2.80	0.44	92.30%	-4,010.00%	-2,872.67%
ENTX	ENTERA BIO LTD	$89.54M	-95.10%	-82.80%	-50.44%	7,950.30%	0.12	13.07	4.00%	-4,525.10%	-4,518.83%
HBIO	HARVARD BIOSCIENCE INC	$21.78M	-144.20%	-55.00%	-215.53%	-104.70%	4.09	0.82	56.90%	-64.70%	-60.45%
LPTX	LEAP THERAPEUTICS INC	$10.11M	-162.70%	-120.50%	-329.07%	508.90%	0.67	2.41	N/A	N/A	N/A
SNOA	SONOMA PHARMACEUTICALS INC	$8.66M	-70.50%	-25.30%	-30.29%	-49.10%	2.10	3.09	38.20%	-24.20%	-20.35%
MYNZ	MAINZ BIOMED NV	$3.92M	-465.80%	-151.20%	-282.30%	-1,734.30%	1.19	1.32	64.30%	-2,421.80%	-2,301.53%
IMRN	IMMURON LTD	$10.37M	-52.80%	-45.90%	-70.35%	-285.20%	0.18	6.80	78.60%	-73.90%	-73.82%
TRIB	TRINITY BIOTECH PLC	$34.30M	N/A	-33.00%	-30.53%	-19.20%	-3.94	1.28	34.80%	-51.60%	-35.31%
VIVS	VIVOSIM LABS INC	$4.68M	-33.00%	-21.40%	-20.06%	-143.80%	0.26	4.52	97.90%	-1,399.30%	-1,389.44%
IPHA	INNATE PHARMA SA	$182.41M	-162.90%	-33.50%	-58.27%	-58.30%	11.57	2.60	100.00%	-245.90%	-226.11%
VNRX	VOLITIONRX LTD	$66.35M	N/A	-220.10%	-9,582.36%	346.90%	-1.35	0.40	100.00%	-1,836.20%	-1,808.71%
THTX	THERATECHNOLOGIES INC	$148.06M	N/A	-15.90%	66.69%	22.00%	-2.84	0.84	77.70%	-10.90%	9.56%
XBIO	XENETIC BIOSCIENCES INC	$4.51M	-54.50%	-47.30%	-69.28%	3,722.20%	0.20	5.93	100.00%	-126.00%	-126.03%
ISPC	ISPECIMEN INC	$2.91M	-285.20%	-114.40%	-576.18%	402.40%	3.10	0.31	38.50%	-139.70%	-137.53%
ITOS	ITEOS THERAPEUTICS INC	$446.92M	-35.50%	-30.10%	-34.38%	-40.10%	0.26	7.53	N/A	N/A	N/A
YMAB	Y-MABS THERAPEUTICS INC	$385.36M	-30.60%	-22.70%	-32.92%	-115.20%	0.26	4.77	81.80%	-31.80%	-34.78%
VRAX	VIRAX BIOLABS GROUP LTD	$3.20M	-109.60%	-101.80%	-108.73%	-324.80%	0.17	7.27	-838.20%	-95,739.20%	-98,816.73%
VYNE	VYNE THERAPEUTICS INC	$5.83M	-71.90%	-59.00%	-95.60%	-119.70%	0.28	4.47	100.00%	-6,974.50%	-6,973.88%
WORX	SCWORX CORP	$1.16M	-31.60%	-21.60%	-21.20%	84.50%	0.28	0.85	23.30%	-49.50%	-40.98%
TRAW	TRAWS PHARMA INC	$9.01M	N/A	-193.20%	-399.54%	492.40%	2.18	1.81	100.00%	-15,245.80%	-15,245.81%
XTNT	XTANT MEDICAL HOLDINGS INC	$84.71M	-10.10%	-4.70%	0.16%	0.10%	1.13	2.47	60.20%	-3.60%	0.09%
XYLO	XYLO TECHNOLOGIES LTD	$4.05M	-57.80%	-23.70%	-64.11%	-246.20%	1.11	1.14	22.40%	-40.20%	-41.07%
ZCMD	ZHONGCHAO INC	$24.63M	-3.30%	-2.60%	-1.26%	-2.00%	0.08	12.22	56.20%	-4.10%	-1.94%
GELS	GELTEQ LTD	$13.40M	N/A	N/A	N/A	N/A	0.34	0.79	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$63.28M	-54.10%	-48.00%	-70.04%	-71.10%	0.19	6.89	N/A	N/A	N/A
GRCE	GRACE THERAPEUTICS INC	$42.59M	-17.30%	-15.40%	-18.95%	862.50%	0.10	8.87	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$20.59M	-24.90%	-22.40%	-26.39%	-62.80%	0.11	9.89	75.40%	-3,621.10%	-3,591.88%
IGC	IGC PHARMA INC	$30.20M	-102.30%	-73.40%	-109.72%	-175.80%	0.38	1.28	48.70%	-560.30%	-560.27%
IMA	IMAGENEBIO INC	$59.48M	-24.90%	-22.50%	-25.78%	-34.00%	0.09	13.52	N/A	N/A	N/A
INDP	INDAPTUS THERAPEUTICS INC	$8.64M	-612.60%	-243.80%	1,013.62%	1,268.40%	-5.09	0.75	N/A	N/A	N/A
INKT	MINK THERAPEUTICS INC	$61.06M	N/A	-140.70%	124.01%	292.10%	-1.20	0.30	N/A	N/A	N/A
IXHL	INCANNEX HEALTHCARE INC	$11.63M	-332.20%	-144.00%	-242.50%	-406.10%	1.19	2.12	100.00%	-22,186.70%	-21,846.94%
KPRX	KIORA PHARMACEUTICALS INC	$7.70M	-42.80%	-32.20%	-34.24%	-46.30%	0.44	5.14	100.00%	-60,257.30%	-49,209.99%
KZR	KEZAR LIFE SCIENCES INC	$29.15M	-63.50%	-52.10%	-73.19%	-72.50%	0.19	7.29	N/A	N/A	N/A
LSB	LAKESHORE BIOPHARMA CO LTD	$16.41M	-18.40%	-6.90%	-15.69%	-10.70%	1.74	1.02	82.50%	-16.30%	-13.85%
NXTC	NEXTCURE INC	$12.03M	-70.20%	-58.10%	-80.66%	-86.50%	0.20	10.26	N/A	N/A	N/A
MDXH	MDXHEALTH SA	$14.06M	-534.90%	-25.00%	-14.88%	-16.30%	28.30	2.00	62.00%	-41.00%	-20.73%
MEIP	MEI PHARMA INC	$32.65M	-127.20%	-110.80%	-162.03%	-283.50%	0.06	16.78	N/A	N/A	N/A
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	$12.41M	7.10%	6.10%	9.52%	10.70%	0.17	5.26	34.40%	11.20%	15.62%
MLEC	MOOLEC SCIENCE SA	$9.78M	-150.90%	-26.60%	-25.84%	-22.10%	10.22	1.48	-8.20%	-105.70%	-82.22%
MLSS	MILESTONE SCIENTIFIC INC	$45.44M	-82.70%	-50.10%	-113.87%	-192.60%	1.04	1.94	74.40%	-61.20%	-61.40%
MOVE	MOVANO INC	$4.21M	-288.40%	-181.30%	-301.30%	2,706.20%	0.54	3.02	-196.80%	-2,342.30%	-2,342.25%
MTVA	METAVIA INC	$15.49M	-212.00%	-107.20%	-191.84%	239.50%	0.92	2.08	N/A	N/A	N/A
NAKA	KINDLY MD INC	$114.25M	-132.20%	-106.90%	-57.87%	-372.90%	0.10	12.99	98.70%	-244.10%	-242.85%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$91.19M	-32.50%	-27.90%	-32.03%	-28.20%	0.18	18.52	N/A	N/A	N/A
NBY	NOVABAY PHARMACEUTICALS INC	$3.52M	163.60%	50.40%	53.80%	279.60%	0.60	2.95	65.60%	37.10%	51.20%
NERV	MINERVA NEUROSCIENCES INC	$12.55M	-20.70%	15.70%	20.27%	9.80%	-2.13	9.21	N/A	N/A	N/A
NEUE	NEUEHEALTH INC	$60.66M	N/A	-18.70%	33.11%	32.60%	-0.83	0.70	24.20%	-15.10%	-6.13%
NXL	NEXALIN TECHNOLOGY INC	$14.02M	-209.20%	-186.90%	-148.47%	-250.60%	0.10	10.44	67.60%	-5,063.00%	-5,064.66%
PCSA	PROCESSA PHARMACEUTICALS INC	$11.08M	-342.40%	-243.50%	-210.93%	-3,727.00%	0.34	3.45	N/A	N/A	N/A
OSRH	OSR HOLDINGS INC	$10.04M	N/A	N/A	N/A	N/A	0.56	0.25	N/A	N/A	N/A
NSYS	NORTECH SYSTEMS INC	$24.16M	-9.70%	-4.50%	-5.61%	-4.20%	1.24	2.77	11.90%	-2.80%	-2.45%
ONMD	ONEMEDNET CORP	$44.21M	N/A	-110.00%	84.62%	48.10%	-1.61	0.37	-125.00%	-728.70%	-703.04%
PIII	P3 HEALTH PARTNERS INC	$49.88M	-192.00%	-18.60%	-48.64%	81.00%	14.49	0.31	-8.00%	-10.00%	-7.54%
PASG	PASSAGE BIO INC	$24.13M	-103.90%	-59.90%	-95.72%	-105.40%	1.07	3.05	N/A	N/A	N/A
PRPH	PROPHASE LABS INC	$13.83M	-230.20%	-67.10%	-154.17%	-66.60%	2.68	0.96	60.40%	-1,241.10%	-757.69%
RADX	RADIOPHARM THERANOSTICS LTD	$32.69M	-105.50%	-52.50%	-50.53%	-174.90%	0.76	3.37	4.00%	-2,427.10%	-2,381.21%
PMCB	PHARMACYTE BIOTECH INC	$6.04M	51.00%	41.70%	58.67%	105.10%	0.06	7.68	N/A	N/A	N/A
POAI	PREDICTIVE ONCOLOGY INC	$9.48M	N/A	-179.60%	2,384.36%	-598.90%	-3.08	0.32	48.50%	-913.60%	-913.57%
PRTC	PURETECH HEALTH PLC	$418.99M	12.20%	8.30%	8.82%	10.70%	0.47	9.33	100.00%	1,108.30%	1,025.31%
PRTG	PORTAGE BIOTECH INC	$14.55M	-347.70%	-135.50%	-602.49%	2,165.50%	-24.81	2.02	N/A	N/A	N/A
PULM	PULMATRIX INC	$18.33M	-97.20%	-89.00%	-141.51%	2,758.30%	0.10	11.21	100.00%	-2,149.10%	-2,149.05%
QLGN	QUALIGEN THERAPEUTICS INC	$2.88M	N/A	-265.90%	-18,182.09%	1,638.90%	84.94	1.01	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$32.64M	-102.60%	-50.60%	2,678.82%	-23,768.00%	-25.86	0.97	N/A	N/A	N/A
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-40.20%	349.59%	139.50%	-4.85	0.54	60.30%	-102.80%	-181.69%
RENB	RENOVARO INC	$40.96M	-66.90%	-52.10%	-74.49%	350.00%	0.33	0.13	N/A	N/A	N/A
RLYB	RALLYBIO CORP	$22.82M	-71.70%	-65.10%	-90.62%	-98.10%	0.11	9.98	100.00%	-5,473.30%	-5,473.32%
RNTX	REIN THERAPEUTICS INC	$25.59M	-81.60%	-73.50%	-121.61%	1,485.10%	0.16	1.39	N/A	N/A	N/A
RPTX	REPARE THERAPEUTICS INC	$66.91M	-78.10%	-67.10%	-101.29%	-151.70%	0.15	7.42	100.00%	-11,919.30%	-11,809.23%
PHAR	PHARMING GROUP NV	$774.19M	-3.60%	-2.00%	1.06%	1.30%	0.86	2.80	89.30%	-2.40%	1.12%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$21.78M	N/A	-302.30%	651.46%	236.40%	-2.59	0.54	N/A	N/A	N/A
SABS	SAB BIOTHERAPEUTICS INC	$20.53M	-105.10%	-69.20%	-119.31%	-94.10%	0.78	1.69	100.00%	-9,071.80%	-8,989.31%
MODD	MODULAR MEDICAL INC	$39.98M	-178.10%	-151.40%	-107.74%	-390.00%	0.10	10.69	N/A	N/A	N/A
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	$0.00	-253.10%	-33.30%	-52.58%	-29.10%	0.35	1.32	-88.10%	-728.90%	-930.24%
SER	SERINA THERAPEUTICS INC	$56.38M	N/A	-168.80%	-233.25%	-2,039.70%	4.05	2.24	100.00%	-9,685.40%	-9,653.08%
QNRX	QUOIN PHARMACEUTICALS LTD	$7.52M	-210.50%	-99.40%	-265.99%	-270.40%	2.49	1.96	N/A	N/A	N/A
SLRX	SALARIUS PHARMACEUTICALS INC	$3.46M	-556.50%	-192.30%	615.07%	512.80%	-2.68	0.61	N/A	N/A	N/A
SNGX	SOLIGENIX INC	$9.60M	-223.90%	-103.50%	-279.76%	385.20%	1.14	1.85	0.00%	-409,394.20%	-431,521.39%
NEPH	NEPHROS INC	$42.40M	9.40%	7.20%	7.95%	12.80%	0.27	5.92	62.40%	5.20%	5.26%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	637	+0.16%	+4.39%	+5.40%	-64.07%	-120.55x	4.49x	-118.72%	-6.90%	-1.22%	+91.91%	Strong Buy
Diagnostics & Research	57	-0.65%	+5.82%	+10.75%	-11.64%	23.48x	3.86x	-3.64%	+7.31%	+15.56%	+6.42%	Buy
Drug Manufacturers - General	18	+1.22%	+4.73%	-2.89%	-13.96%	35.06x	5.95x	+58.83%	+10.36%	+17.82%	+52.31%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.28%	+7.01%	+1.44%	-66.95%	-12.37x	2.25x	+12.30%	+4.94%	+10.47%	+33.61%	Buy
Healthcare Plans	11	+0.15%	+7.00%	-6.09%	-38.26%	13.93x	1.88x	+15.64%	+4.90%	+11.41%	+25.76%	Buy
Health Information Services	55	-0.70%	+5.29%	+3.12%	-55.42%	83.62x	4.08x	+7.18%	+4.90%	+9.58%	+21.87%	Strong Buy
Medical Care Facilities	48	-0.63%	+4.80%	+0.49%	-32.55%	15.96x	4.72x	-194.68%	+6.86%	+15.22%	+19.15%	Buy
Medical Devices	141	-0.80%	+4.06%	-1.62%	-20.79%	31.63x	4.01x	+13.96%	+8.53%	+10.15%	+30.11%	Strong Buy
Medical Distribution	10	+1.29%	+2.12%	-4.82%	+20.45%	26.54x	286.70x	-6.88%	+3.01%	+18.69%	+15.90%	Buy
Medical Instruments & Supplies	55	-1.07%	+2.00%	+0.19%	-60.20%	33.51x	3.51x	+10.62%	+8.37%	+11.14%	+23.54%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 20 points higher than the healthcare sector average of 25. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 70.29% over the past year, overperforming other healthcare stocks by 119 percentage points.

Phibro Animal Health has an average 1 year price target of $30.50, a downside of -0.23% from Phibro Animal Health's current stock price of $30.57.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: D, Sentiment: B, Safety: D, Financials: A, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 11 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -6.1% over the past year, overperforming other healthcare stocks by 42 percentage points.

Embecta has an average 1 year price target of $12.00, a downside of -13.48% from Embecta's current stock price of $13.87.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 59.39% over the past year, overperforming other healthcare stocks by 108 percentage points.

Theravance Biopharma has an average 1 year price target of $21.33, an upside of 64.86% from Theravance Biopharma's current stock price of $12.94.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Simulations Plus (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.95%. Simulations Plus's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Simulations Plus's dividend has shown consistent growth over the last 10 years.

Simulations Plus's dividend payout ratio of -1.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.95%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

3. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.1%, which is 12 percentage points higher than the healthcare sector average of 1.95%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.19% in the last day, and up 4.59% over the last week. Onemednet was the among the top losers in the healthcare sector, dropping -33.06% yesterday.

OneMedNet shares are trading higher after the company reported a year-over-year increase in Q2 EPS results.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -6.1% in the past year. It has overperformed other stocks in the healthcare sector by 42 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 4.6% in the past year. It has overperformed other stocks in the healthcare sector by 53 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 116.23% in the past year. It has overperformed other stocks in the healthcare sector by 165 percentage points.

Are healthcare stocks a good buy now?

50.6% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.32% over the next year.

5.45% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.32% of healthcare stocks are rated B (Buy), 42.3% are rated C (Hold), 26.54% are rated D (Sell), and 13.39% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 6.78x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.